Mark C. Wiggins, EVP Corporate and Business Development at BIOGEN IDEC INC. (BIIB), sold 14,006 shares at $60.64 ($857K) on 2008-02-06, disclosed to the SEC on 2008-02-07.
Scheduled sale ($857k) by EVP Corporate and Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.52 | 2,081 | $126K | 14.7% |
| 2 | $60.64 | 100 | $6K | 0.7% |
| 3 | $60.69 | 225 | $14K | 1.6% |
| 4 | $60.80 | 800 | $49K | 5.7% |
| 5 | $60.81 | 200 | $12K | 1.4% |
| 6 | $60.99 | 200 |
| $12K |
| 1.4% |
| 7 | $61.08 | 700 | $43K | 5.0% |
| 8 | $61.10 | 400 | $24K | 2.9% |
| 9 | $61.11 | 1,600 | $98K | 11.4% |
| 10 | $61.12 | 600 | $37K | 4.3% |
| 11 | $61.13 | 600 | $37K | 4.3% |
| 12 | $61.14 | 400 | $24K | 2.9% |
| 13 | $61.15 | 600 | $37K | 4.3% |
| 14 | $61.16 | 300 | $18K | 2.1% |
| 15 | $61.17 | 500 | $31K | 3.6% |
| 16 | $61.18 | 300 | $18K | 2.1% |
| 17 | $61.19 | 600 | $37K | 4.3% |
| 18 | $61.22 | 100 | $6K | 0.7% |
| 19 | $61.23 | 200 | $12K | 1.4% |
| 20 | $61.60 | 300 | $18K | 2.2% |
| 21 | $61.61 | 100 | $6K | 0.7% |
| 22 | $61.70 | 100 | $6K | 0.7% |
| 23 | $61.87 | 3,000 | $186K | 21.7% |
| Total | $61.18 avg | 14,006 | $857K | 100% |
| Filing → |
| ZGNX | BUY | 2020-03-24 | $51K | — | Filing → |
| TCON | BUY | 2020-01-24 | $20K | — | Filing → |
| ZGNX | SELL | 2019-08-12 | $313K | — | Filing → |